{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:26:24Z","timestamp":1790375184568,"version":"4.1.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>OBJECTIVE. The goal was to investigate the clinical impact of 3 early management practice changes for infants of \u22641000 g.<\/jats:p><jats:p>METHODS. We performed an historical cohort study of appropriately sized, preterm infants without congenital anomalies who were born between January 2001 and June 2002 (pre\u2013early management practice change group; n = 87) and between July 2004 and December 2005 (post\u2013early management practice change group; n = 76).<\/jats:p><jats:p>RESULTS. Only 1 (1%) of 87 infants in the pre\u2013early management practice change group received continuous positive airway pressure treatment in the first 24 hours of life, compared with 61 (80%) of 76 infants in the post\u2013early management practice change group. The proportions of infants who required any synchronized intermittent mandatory ventilation during their hospital stays were 98.8% and 59.5%, respectively. The mean durations of synchronized intermittent mandatory ventilation were 35 days and 15 days, respectively. The combined incidence rates of moderate and severe bronchopulmonary dysplasia at corrected gestational age of 36 weeks were 43% and 24%, respectively. The use of vasopressor support for hypotension in the first 24 hours of life decreased from 39.1% (before early management practice changes) to 19.7% (after practice changes), the cumulative days of oxygen therapy decreased from 77 \u00b1 52 days to 56 \u00b1 47 days, and the proportions of infants discharged with home oxygen therapy decreased from 25.7% to 10.1%; the incidence of patent ductus arteriosus requiring surgical ligation increased from 1% to 10%.There were no differences in rates of death, intraventricular hemorrhage, periventricular leukomalacia, pneumothorax, necrotizing enterocolitis, or retinopathy of prematurity.<\/jats:p><jats:p>CONCLUSIONS. Successful early management of extremely preterm infants with surfactant treatment followed by continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid supplementation is possible and is associated with reductions in the incidence and severity of bronchopulmonary dysplasia.<\/jats:p>","DOI":"10.1542\/peds.2007-0225","type":"journal-article","created":{"date-parts":[[2007,12,31]],"date-time":"2007-12-31T17:23:13Z","timestamp":1199121793000},"page":"89-96","source":"Crossref","is-referenced-by-count":68,"title":["Decreased Incidence of Bronchopulmonary Dysplasia After Early Management Changes, Including Surfactant and Nasal Continuous Positive Airway Pressure Treatment at Delivery, Lowered Oxygen Saturation Goals, and Early Amino Acid Administration: A Historical Cohort Study"],"prefix":"10.1542","volume":"121","author":[{"given":"Cara","family":"Geary","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Caskey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malloy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"2021120902184087300_R1","doi-asserted-by":"crossref","unstructured":"Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med.\u20081967;276:357\u2013368","DOI":"10.1056\/NEJM196702162760701"},{"key":"2021120902184087300_R2","doi-asserted-by":"crossref","unstructured":"Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr.\u20082001;13:124\u2013129","DOI":"10.1097\/00008480-200104000-00006"},{"key":"2021120902184087300_R3","doi-asserted-by":"crossref","unstructured":"Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease?Pediatrics.\u20082000;105:1194\u20131201","DOI":"10.1542\/peds.105.6.1194"},{"key":"2021120902184087300_R4","doi-asserted-by":"crossref","unstructured":"Turunen R, Nupponen I, Siitonen S, et al. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Pediatrics.\u20082006;117:448\u2013454","DOI":"10.1542\/peds.2005-0123"},{"key":"2021120902184087300_R5","doi-asserted-by":"crossref","unstructured":"Groneck P, Speer C. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed.\u20081995;73:1F\u20133F","DOI":"10.1136\/fn.73.1.F1"},{"key":"2021120902184087300_R6","doi-asserted-by":"crossref","unstructured":"Ehrenkranz R, Walsh M, Vohr B, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics.\u20082005;116:1353\u20131360","DOI":"10.1542\/peds.2005-0249"},{"key":"2021120902184087300_R7","doi-asserted-by":"crossref","unstructured":"Vohr B, Wright L, Dusick A, et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics.\u20082004;113:781\u2013789","DOI":"10.1542\/peds.113.4.781"},{"key":"2021120902184087300_R8","doi-asserted-by":"crossref","unstructured":"Narendran V, Donovan E, Hoath S, et al. Early bubble CPAP and outcomes in ELBW preterm infants. J Perinatol.\u20082003;23:195\u2013199","DOI":"10.1038\/sj.jp.7210904"},{"key":"2021120902184087300_R9","doi-asserted-by":"crossref","unstructured":"Meyer M, Mildenhall L, Wong M. Outcomes for infants weighing less than 1000 grams cared for with a nasal positive airway pressure-based strategy. J Paediatr Child Health.\u20082004;40:38\u201341","DOI":"10.1111\/j.1440-1754.2004.00287.x"},{"key":"2021120902184087300_R10","doi-asserted-by":"crossref","unstructured":"Jegatheesan P, Keller RL, Hawgood S. Early variable-flow nasal continuous positive airway pressure in infants \u22641000 grams at birth. J Perinatol.\u20082006;26:189\u2013196","DOI":"10.1038\/sj.jp.7211454"},{"key":"2021120902184087300_R11","doi-asserted-by":"crossref","unstructured":"Jackson JK, Biondo DJ, Jones JM, et al. Can an alternative umbilical arterial catheter solution and flush regimen decrease iatrogenic hemolysis while enhancing nutrition? A double-blind, randomized, clinical trial comparing an isotonic amino acid with a hypotonic salt infusion. Pediatrics.\u20082004;114:377\u2013383","DOI":"10.1542\/peds.114.2.377"},{"key":"2021120902184087300_R12","doi-asserted-by":"crossref","unstructured":"Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics.\u20081987;79:26\u201330","DOI":"10.1542\/peds.79.1.26"},{"key":"2021120902184087300_R13","doi-asserted-by":"crossref","unstructured":"Linder W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation?Pediatrics.\u20081999;103:961\u2013967","DOI":"10.1542\/peds.103.5.961"},{"key":"2021120902184087300_R14","doi-asserted-by":"crossref","unstructured":"DeKlerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Pediatr.\u20082001;37:161\u2013167","DOI":"10.1046\/j.1440-1754.2001.00624.x"},{"key":"2021120902184087300_R15","doi-asserted-by":"crossref","unstructured":"Aly H. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics.\u20082001;108:759\u2013761","DOI":"10.1542\/peds.108.3.759"},{"key":"2021120902184087300_R16","doi-asserted-by":"crossref","unstructured":"Aly H, Milner JD, Patel K, El-Mohandes AAE. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birthweight infants?Pediatrics.\u20082004;114:697\u2013702","DOI":"10.1542\/peds.2003-0572-L"},{"key":"2021120902184087300_R17","doi-asserted-by":"crossref","unstructured":"Kirchner L, Weninger M, Unterasinger L, et al. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years experience with the Vermont Oxford Neonatal Network. J Perinatal Med.\u20082004;33:60\u201366","DOI":"10.1515\/JPM.2005.010"},{"key":"2021120902184087300_R18","doi-asserted-by":"crossref","unstructured":"Gitterman MK, Fusch C, Gittermann AR, et al. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birthweight infants. Eur J Pediatr.\u20081997;156:384\u2013388","DOI":"10.1007\/s004310050620"},{"key":"2021120902184087300_R19","doi-asserted-by":"crossref","unstructured":"Dani C, Bertini G, Pezzati M, et al. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants &lt;30 weeks gestation. Pediatrics.\u20082004;113(6). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/6\/e560","DOI":"10.1542\/peds.113.6.e560"},{"key":"2021120902184087300_R20","doi-asserted-by":"crossref","unstructured":"Reininger A, Khalak R, Kendig J, et al. Surfactant administration by transient intubation in infants 29\u201335 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol.\u20082005;25:703\u2013708","DOI":"10.1038\/sj.jp.7211381"},{"key":"2021120902184087300_R21","doi-asserted-by":"crossref","unstructured":"Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics.\u20081999;103(2). Available at: www.pediatrics.org\/cgi\/content\/full\/103\/2\/e24","DOI":"10.1542\/peds.103.2.e24"},{"key":"2021120902184087300_R22","doi-asserted-by":"crossref","unstructured":"Dunn M, Shennan A, Zayack D, et al. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics.\u20081991;87:377\u2013386","DOI":"10.1542\/peds.87.3.377"},{"key":"2021120902184087300_R23","doi-asserted-by":"crossref","unstructured":"OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant: the judgment of OSIRIS. Lancet.\u20081992;340:1363\u20131369","DOI":"10.1016\/0140-6736(92)92557-V"},{"key":"2021120902184087300_R24","doi-asserted-by":"crossref","unstructured":"Finer N, Carlo W, Duara S, et al. Delivery room continuous positive airway pressure\/positive end-expiratory pressure in extremely low birthweight infants: a feasibility trial. Pediatrics.\u20082004;114:651\u2013657","DOI":"10.1542\/peds.2004-0394"},{"key":"2021120902184087300_R25","doi-asserted-by":"crossref","unstructured":"Mulrooney N, Champion Z, Moss TJ, et al. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med.\u20082005;171:488\u2013493","DOI":"10.1164\/rccm.200406-774OC"},{"key":"2021120902184087300_R26","doi-asserted-by":"crossref","unstructured":"Ammari A, Suri M, Milisavljevic V, et al. Variables associated with the early failure of nasal CPAP in very low birthweight infants. J Pediatr.\u20082005;147:341\u2013347","DOI":"10.1016\/j.jpeds.2005.04.062"},{"key":"2021120902184087300_R27","doi-asserted-by":"crossref","unstructured":"STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial, part I: primary outcomes. Pediatrics.\u20082000;105:295\u2013310","DOI":"10.1542\/peds.105.2.295"},{"key":"2021120902184087300_R28","doi-asserted-by":"crossref","unstructured":"Deulofeut R, Critz A, Adams-Chapman I, et al. Avoiding hyperoxia in infants \u22641250 g is associated with improved short- and long-term outcomes. J Perinatol.\u20082006;26:700\u2013705","DOI":"10.1038\/sj.jp.7211608"},{"key":"2021120902184087300_R29","doi-asserted-by":"crossref","unstructured":"Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, et al. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol.\u20082006;26:428\u2013435","DOI":"10.1038\/sj.jp.7211538"},{"key":"2021120902184087300_R30","doi-asserted-by":"crossref","unstructured":"Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol.\u20082006;30:200\u2013208","DOI":"10.1053\/j.semperi.2006.05.007"},{"key":"2021120902184087300_R31","doi-asserted-by":"crossref","unstructured":"Spears K, Cheney C, Zerzan J. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants. Am J Clin Nutr.\u20082004;80:1589\u20131594","DOI":"10.1093\/ajcn\/80.6.1589"},{"key":"2021120902184087300_R32","doi-asserted-by":"crossref","unstructured":"Frank L, Sosenko IR. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis.\u20081988;138:725\u2013729","DOI":"10.1164\/ajrccm\/138.3.725"},{"key":"2021120902184087300_R33","doi-asserted-by":"crossref","unstructured":"Thureen P, Melara D, Fennessey P, et al. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res.\u20082003;53:24\u201332","DOI":"10.1203\/00006450-200301000-00008"},{"key":"2021120902184087300_R34","doi-asserted-by":"crossref","unstructured":"Poindexter B, Langer J, Dusick A, et al. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr.\u20082001;148:300\u2013305","DOI":"10.1016\/j.jpeds.2005.10.038"},{"key":"2021120902184087300_R35","doi-asserted-by":"crossref","unstructured":"Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol.\u20082006;26(suppl 1):S14\u2013S18","DOI":"10.1038\/sj.jp.7211465"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/89\/1122624\/zpe00108000089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/89\/1122624\/zpe00108000089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:40:16Z","timestamp":1684161616000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/1\/89\/71001\/Decreased-Incidence-of-Bronchopulmonary-Dysplasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,1]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0225","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}